The Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Is Associated with the Recovered Ejection Fraction in Patients with Dilated Cardiomyopathy-Reference-Cited by-同舟云学术

The Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Is Associated with the Recovered Ejection Fraction in Patients with Dilated Cardiomyopathy

Published:2021-07-30 Issue:4 Volume:62 Page:801-810
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Enzan Nobuyuki¹,Matsushima Shouji¹,Ide Tomomi²,Kaku Hidetaka³,Tohyama Takeshi⁴,Funakoshi Kouta⁴,Higo Taiki¹,Tsutsui Hiroyuki¹

Affiliation:

1. Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University

2. Department of Experimental and Clinical Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

3. Department of Cardiology, Japan Community Healthcare Organization Kyushu Hospital

4. Center for Clinical and Translational Research, Kyushu University Hospital

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/62/4/62_20-671/_pdf

Reference29 articles.

1. 1. Hellawell JL, Margulies KB. Myocardial reverse remodeling. Cardiovasc Ther 2012; 30: 172-81.

2. 2. Punnoose LR, Givertz MM, Lewis EF, Pratibhu P, Stevenson LW, Desai AS. Heart failure with recovered ejection fraction: a distinct clinical entity. J Card Fail 2011; 17: 527-32.

3. 3. Florea VG, Rector TS, Anand IS, Cohn JN. Heart failure with improved ejection fraction: clinical characteristics, correlates of recovery, and survival: results from the valsartan heart failure trial. Circ Heart Fail 2016; 9.

4. 4. Kalogeropoulos AP, Fonarow GC, Georgiopoulou V, et al. Characteristics and outcomes of adult outpatients with heart failure and improved or recovered ejection fraction. JAMA Cardiol 2016; 1: 510-8.

5. 5. Jørgensen ME, Andersson C, Vasan RS, Køber L, Abdulla J. Characteristics and prognosis of heart failure with improved compared with persistently reduced ejection fraction: A systematic review and meta-analyses. Eur J Prev Cardiol 2018; 25: 366-76.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with improved ejection fraction: Beyond diagnosis to trajectory analysis;Progress in Cardiovascular Diseases;2024-01

2. A Case of Significant Improvement of Heart Failure With Reduced Ejection Fraction With a Small Dose of Candesartan in a Hemodialysis Patient With Hypertensive Heart Disease and Nephrosclerosis;Cureus;2023-09-11

3. Evaluation of the pharmacotherapeutic impact on contractility recovery in patients with newly diagnosed, acute onset dilated cardiomyopathy;Medicine;2023-06-16

4. Mechanism of angiotensin-converting enzyme inhibitors in the treatment of dilated cardiomyopathy based on a protein interaction network and molecular docking;Cardiovascular Diagnosis and Therapy;2023-06

5. Nationwide Temporal Trends in Clinical Characteristics and Treatment of Dilated Cardiomyopathy From 2003 to 2013 in Japan　― A Report From Clinical Personal Records ―;Circulation Journal;2023-03-24